Cargando…
Stimulation of B Cell Immunity in Flavivirus-Naive Individuals by the Tetravalent Live Attenuated Dengue Vaccine TV003
The tetravalent live attenuated dengue vaccine candidate TV003 induces neutralizing antibodies against all four dengue virus serotypes (DENV1–DENV4) and protects against experimental challenge with DENV2 in humans. Here, we track vaccine viremia and B and T cell responses to this vaccination/challen...
Autores principales: | Tu, Huy A., Nivarthi, Usha K., Graham, Nancy R., Eisenhauer, Philip, Delacruz, Matthew J., Pierce, Kristen K., Whitehead, Stephen S., Boyson, Jonathan E., Botten, Jason W., Kirkpatrick, Beth D., Durbin, Anna P., deSilva, Aravinda M., Diehl, Sean A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762770/ https://www.ncbi.nlm.nih.gov/pubmed/33377126 http://dx.doi.org/10.1016/j.xcrm.2020.100155 |
Ejemplares similares
-
In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination
por: Whitehead, Stephen S., et al.
Publicado: (2017) -
A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans
por: Nivarthi, Usha K., et al.
Publicado: (2021) -
Rapid Induction and Maintenance of Virus-Specific CD8(+) T(EMRA) and CD4(+) T(EM) Cells Following Protective Vaccination Against Dengue Virus Challenge in Humans
por: Graham, Nancy, et al.
Publicado: (2020) -
Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico
por: Dayan, Gustavo H, et al.
Publicado: (2014) -
Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model
por: Nivarthi, Usha K., et al.
Publicado: (2019)